Test Price
2,800 AED✅ Home Collection Available
RUNX1 Gene Leukemia, Acute Myeloid Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل طفرة جين RUNX1 لابيضاض الدم النقوي الحاد بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي 2026
الملخص التنفيذي
- ضمان الدقة: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- الخدمات اللوجستية المتميزة: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- الإرشاد السريري: Telephonic Post-Test Clinical Guidance in result interpretation.
- التأمين: Direct Billing Verification via WhatsApp at +971 54 548 8731.
- الامتثال التنظيمي: Full adherence to Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL.
Overview
The RUNX1 Genetic Test identifies germline and somatic mutations in the RUNX1 gene associated with acute myeloid leukemia (AML) and familial platelet disorder with predisposition to myeloid malignancies. This test is essential for accurate diagnosis, risk stratification, and guiding targeted therapy decisions. يُعد تحليل طفرة جين RUNX1 بتقنية التسلسل الجيني من الجيل التالي أداة تشخيصية دقيقة تكشف الطفرات الموروثة والمكتسبة المرتبطة بسرطان الدم النقوي الحاد، مما يساعد في تحديد العلاج المناسب وتقييم المخاطر العائلية.
| Feature | Our Test (NGS) | Sanger Sequencing (Closest Alternative) |
|---|---|---|
| Precision | Full gene coverage, detects novel variants | Targeted exon analysis, limited to known mutations |
| Method | Next-Generation Sequencing (NGS) | Capillary Electrophoresis Sanger |
| Turnaround Time | 3–4 Weeks (comprehensive analysis) | 2–3 Weeks (per gene region) |
Physician Insight & Safety Protocol
“As a clinical pathologist with decades of experience, I understand the anxiety a leukemia diagnosis brings. This high-precision NGS test offers clarity by identifying actionable RUNX1 mutations, but results must always be interpreted alongside your full clinical picture. Please remember that no single test replaces the nuanced judgment of your treating hematologist or oncologist.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This test does not replace emergency medical evaluation.
Exclusion Criteria & ER Red Flags
- Active severe infection or sepsis – postpone non-urgent genetic testing.
- Uncontrolled bleeding or platelet count <20×10⁹/L – phlebotomy risk assessed by clinician.
- Acute promyelocytic leukemia (APL) symptoms (e.g., sudden bruising, coagulopathy) – seek immediate emergency care.
- New neurological deficits or signs of leukostasis (visual changes, hypoxia) – immediate ER visit required.
- Pregnancy – discuss risk-benefit with maternal-fetal medicine specialist before sample collection.
Clinical Entity Grounding
Primary Specialists
- Hematologist
- Medical Oncologist
- Clinical Geneticist
2026 ICD-10-CM Codes
- C92.00 – Acute myeloid leukemia, not having achieved remission
- D46.9 – Myelodysplastic syndrome, unspecified
- Z15.02 – Genetic susceptibility to malignant neoplasm of hematopoietic & lymphoid tissue
LOINC Code
81256-4 – RUNX1 gene mutations found in Blood or Tissue by Sequencing
ISO 9001:2015 Cert: INT/EGQ/2509DA/3139
Patient FAQ & Clinical Guidance
What is the purpose of the RUNX1 gene test in leukemia? ما الهدف من اختبار جين RUNX1 في سرطان الدم؟
The RUNX1 Genetic identifies mutations linked to acute myeloid leukemia to guide diagnosis, prognosis, and familial risk assessment. It distinguishes between sporadic and inherited forms, helping tailor chemotherapy protocols and hematopoietic stem cell transplant decisions. Results are interpreted by a board-certified hematopathologist for clinical correlation.
How should I prepare for the blood collection? كيف أستعد لسحب عينة الدم؟
No fasting or medication changes are required; routine DNA extraction from whole blood or FTA card is unaffected by meals. Inform the phlebotomist of all anticoagulants, but never stop prescribed therapy without medical advice. Our VIP mobile phlebotomy team ensures a stress-free home draw with strict cold-chain transport to the laboratory.
When will I receive results and how are they delivered? متى سأحصل على النتائج وكيف يتم تسليمها؟
The full NGS report, reviewed by Dr. Reddy, is issued within 3 to 4 weeks in a secure, DHA-compliant electronic format. You will receive a telephonic consultation to interpret the findings and understand the implications for your treatment or family screening. Urgent preliminary results can be expedited for active clinical decision-making upon request.
Powered by ISO 9001:2015 certified laboratory. DHA Legal Compliance: Federal Decree-Law No. 41 of 2024, CDS Law 2026, UAE PDPL. All patient data processed under strict confidentiality.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians